GlassScriptPhysician profile
Cindy J Michael
NPI 1609100973
$1,466.44
in general payments reported to CMS, 2019-2025
14 companies · $63.51 in 2025
The $63.51 reported for 2025 was less than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $30.80 · 2022: $20.40 · 2023: $1,352 · 2025: $63.51.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,415.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,415.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $381.01 | 2023 | |
| Otsuka America Pharmaceutical, INC. | $280.24 | 2023 | Rexulti, Abilify Maintena, Abilify Asimtufii |
| Teva Pharmaceuticals USA, INC. | $224.19 | 2023 | Austedo, Austedo Xr, Uzedy |
| Idorsia Pharmaceuticals US INC | $146.92 | 2023 | Quviviq |
| Alkermes, INC. | $144.96 | 2023 | Aristada, Lybalvi |
| Janssen Pharmaceuticals, INC | $109.65 | 2023-2025 | Spravato, Invega Sustenna |
| Genentech USA, INC. | $38.40 | 2021-2022 | |
| Axsome Therapeutics, INC. | $32.68 | 2023 | Auvelity |
| Lundbeck LLC | $26.67 | 2025 | Rexulti |
| Takeda Pharmaceuticals U.S.A., INC. | $20.59 | 2023 | Trintellix |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $19.86 | 2023 | |
| Neurocrine Biosciences, INC. | $14.32 | 2023 | Ingrezza |
| Merck Sharp & Dohme LLC | $14.15 | 2023 | Belsomra |
| Csl Behring | $12.80 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cindy Michael listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.